Macromoltek
Pioneering biotech company specializing in computational modeling and artificial intelligence to design next-generation antibodies for biotech and pharmaceutical partners.
About Macromoltek
Macromoltek: Revolutionizing antibody design.
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Products
Integrated AI-driven computational platform for antibody discovery and engineering, covering AI-driven discovery, computational structure modeling, and custom antibody engineeri...
Security and compliance
No security details published yet
Macromoltek hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Macromoltek